Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Xolair
Pharma
FDA approves Roche, Novartis' Xolair for common food allergies
On the market for two decades for asthma, Novartis and Roche’s Xolair has gained an FDA approval to prevent severe outcomes from food allergies.
Kevin Dunleavy
Feb 16, 2024 2:28pm
Roche's Xolair moves closer to food allergy approval from FDA
Dec 19, 2023 1:01pm
FDA rejects Sanofi, Regeneron's Dupixent to treat hives disorder
Oct 23, 2023 10:38am
Sanofi's Dupixent comes up short, stops hives trial
Feb 18, 2022 10:35am
Genentech, Novartis get FDA nod for self-injectable Xolair
Apr 16, 2021 1:15pm
Sulzer to buy Haselmeier for access to its drug applicators
Aug 24, 2020 7:44am